Treprostinil HCPLive - Search Videos

Future Directions in ATTR-CM | HCPLive

Future Directions in ATTR-CM | HCPLive

Diabetes Dialogue: ATTD 2026 Recap | HCPLive

Diabetes Dialogue: ATTD 2026 Recap | HCPLive

Emerging Therapies in Hypoparathyroidism | HCPLive

Emerging Therapies in Hypoparathyroidism | HCPLive

Hepatitis in 2025: Year in Review | HCPLive

Hepatitis in 2025: Year in Review | HCPLive

Gastroenterology in 2025: Year in Review | HCPLive

Gastroenterology in 2025: Year in Review | HCPLive

Current Treatment Landscape in Psoriatic Arthritis | HCPLive

Current Treatment Landscape in Psoriatic Arthritis | HCPLive

Other Emerging TYK2 Inhibitors in Psoriasis | HCPLive

Other Emerging TYK2 Inhibitors in Psoriasis | HCPLive

Inflammation Emerges as Promising CKD Treatment Target, With Vlado Perkovic, MBBS, PhD | HCPLive

Rethinking Diabetic and Hypertensive CKD Through the Lens of Precision Medicine | HCPLive

Experts Discuss the REPLENISH Trial for Polymyalgia Rheumatica | HCPLive

Understanding the 2026 Dyslipidemia Guidelines: New Risk Tools for Management | HCPLive

Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy | HCPLive

Cardamyst (Etripamil) Nasal Spray Now Commercially Available for Adults with PSVT | HCPLive

Twice-Yearly Depemokimab Reduces Rescue Use in Recurrent CRSwNP, With Josesph Han, MD | HCPLive

UChicago Advances IBD Trials With Focus on Microbiome and Access | HCPLive

Beyond Mifepristone: Enzyme Inhibitors, Pituitary-targeted Agents, and Emerging Therapies | HCPLive

Evinacumab May Lower Triglycerides in Severe Hypertriglyceridemia, With Robert Rosenson, MD | HCPLive

Diabetes Dialogue: Breaking New Ground With Oral GLP-1s in Cardiology and Weight Loss | HCPLive

Endocrinology | Clinical | HCPLive

Medication Review: Clinical Pearls for PAH & PH-ILD Management with Tyvaso DPI (Treprostinil Inhalaton Powder)

Case Study 2: Rheumatoid Arthritis Patient Case Overview and Therapeutic Goals | HCPLive

Liver Lineup: Breakthroughs in Cholestatic Liver Disease in 2025 | HCPLive

Insmed Shares Rise After Phase 2b Trial of Treprostinil Inhalation Powder in PAH Meets Endpoints

marketscreener.com

TRIUMPH-4: Topline Data Highlights Retatrutide's Significant Weight Loss Effects

270 views1 month ago

S01E26: TETON-2 and IPF — Does Inhaled Treprostinil Change Practice?

4 views3 weeks ago

YouTubePRISM Rounds (Pulm Critical Care Sleep Med)

The flu has long been associated with severe cardiac events, but the mechanism behind this connection has never been clear. In an interview with Jeffrey Downey, PhD, from Mount Sinai, we discuss the breakthrough study that's pinpointed the process at fault. Watch now: interferon-1-responsible-for-causing-cardiac-events-during-influenza-infection-with-jeffrey-downey-phd | HCPLive

111 views1 month ago

FacebookHCPLive

TYVASO DPI® (treprostinil) Inhalation Powder | See link in bio for Safety Info. No cleaning required. Just breathe and go. This information is provided for educational purposes only... | Instagram

46 views2 months ago

Instagramtyvasodpi

join me as I mix my Treprostinil medication. #PAH #lungtransplant #Mylife #believeinthefight

267 views4 months ago

TikToklashundrakeeton

The relationship between inflammation and chronic kidney disease (CKD) progression continues to strengthen. Results from the FLOW and SELECT trials support the concept that GLP‑1 receptor agonists like semaglutide may have kidney and cardiovascular benefits partly driven by anti‑inflammatory effects—independent of weight or glucose control. As Vlado Perkovic noted, the roughly 40% reduction in CRP observed in FLOW reinforces inflammation as a meaningful and potentially modifiable aspect of CKD m

10 views1 month ago

FacebookHCPLive

As we end Heart Failure Awareness Week 2026, take some time to learn where we can help to spread awareness about this debilitating disease - and the plethora of treatments and interventions that can prevent it from upending patients' lives. Watch now: https://hubs.li/Q0434FMS0 | HCPLive

30 views1 month ago

FacebookHCPLive

See more